Market Overview

OPKO Health Buys Silcon Comércio, Importacao E Exportacao de Produtos Farmaceuticos e Cosmeticos

Share:
Related OPK
These 3 CEOs Are Still Making Insider Purchases
8 Biggest Mid-Day Gainers For Tuesday
Biotech Forum Daily Digest: Will Biotech Finally Break Out? All Eyes On Gilead, Spotlight On Seres Therapeutics (Seeking Alpha)

OPKO Health, Inc. (NYSE: OPK) has entered into a definitive agreement to acquire Silcon Comércio, Importacao E Exportacao de Produtos Farmaceuticos e Cosmeticos Ltda. Domiciled in Sao Paulo, Brazil, Silcon expands OPKO's presence in Latin America and complements business activities of units in Chile and Mexico.

Silcon broadens OPKO's reach in Latin America with this entry into the largest market in the region. Beyond providing important cross marketing opportunities for its growing portfolio of products, Silcon represents an important strategic element for OPKO's diagnostic business; it permits commercialization of the 4KScore™ prostate cancer test in Brazil as a reference laboratory test while OPKO obtains local approval to market its point of care microfluidics disposable test cassettes.

Posted-In: News M&A

 

Related Articles (OPK)

View Comments and Join the Discussion!